Table 2.

Clinicopathological characteristics among three molecular subtypes.

Characteristics		C1	C2	C3	P-value
Age (years)	≤50	12	37	24	0.031
	>50	63	90	116
Gender	Female	10	50	49	<0.001
	Male	65	77	91
Inducement	Yes	45	107	89	<0.001
	No	30	20	51
Hepatitis virus infection	Yes	35	41	65	0.027
	No	35	86	80
ECOG score	<2	65	95	120	0.033
	≥2	10	32	20
Pathologic T	T1	32	51	85	0.005
	T2	20	35	29
	T3	21	36	17
	T4	1	5	7
Pathologic N	N0	53	97	89	0.240
	N1	0	3	0
Pathologic M	M0	55	97	92	0.616
	M1/MX	0	1	2
Tumor TNM stage	I	30	50	81	0.003
	II	19	31	27
	III	21	41	18
	IV	0	1	2
Gleason grade	G1	17	8	28	<0.001
	G2	33	55	73
	G3	21	54	36
	G4	2	8	2
Survival status	Alive	54	66	99	0.002
	Dead	21	61	41

TNM stage, ACJJ 6^TH or 7^TH TNM stage; Inducement, factors associated with the occurrence of HCC; Hepatitis virus, Hepatitis B and/or hepatitis C viruses; ECOG, Eastern Cooperative Oncology Group.